Search

everythinglearnresearchcommunity

for

Search:↓

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

Deleting MPZL3 increases skin oil production and reduces body fat.

JAK inhibitors can enter the skin through hair follicles using a unique pathway.

RIPK1 inhibitors might help prevent alopecia areata.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

People with weakened immune systems, like those with SLE, are at higher risk for TB.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Type I interferons play a key role in the development of various skin diseases.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

A new genetic mutation in the hairless gene causes a rare hair loss disorder.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.